Literature DB >> 20976841

Daily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation.

Ashley M Lakner1, Cathy C Moore, Alyssa A Gulledge, Laura W Schrum.   

Abstract

AIM: To identify signaling pathways and genes that initiate and commit hepatic stellate cells (HSCs) to transdifferentiation.
METHODS: Primary HSCs were isolated from male Sprague-Dawley rats and cultured on plastic for 0-10 d. Gene expression was assessed daily (quiescent to day 10 culture-activation) by real time polymerase chain reaction and data clustered using AMADA software. The significance of JAK/STAT signaling to HSC transdifferentiation was determined by treating cells with a JAK2 inhibitor.
RESULTS: Genetic cluster analyses, based on expression of these 21 genes, showed similar expression profiles on days 1-3, days 5 and 6, and days 7-10, while freshly isolated cells (day Q) and day 4 cells were genotypically distinct from any of the other days. Additionally, gene expression clustering revealed strong upregulation of interleukin-6, JAK2 and STAT3 mRNA in the early stages of activation. Inhibition of the JAK/STAT signaling pathway impeded the morphological transdifferentiation of HSCs which correlated with decreased mRNA expression of several profibrotic genes including collagens, α-SMA, PDGFR and TGFβR.
CONCLUSION: These data demonstrate unique clustered genetic profiles during the daily progression of HSC transdifferentiation and that JAK/STAT signaling may be critical in the early stages of transdifferentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20976841      PMCID: PMC2965281          DOI: 10.3748/wjg.v16.i40.5047

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Involvement of C/EBP-alpha gene in in vitro activation of rat hepatic stellate cells.

Authors:  Guang-Cun Huang; Jin-Sheng Zhang; Qi-Qun Tang
Journal:  Biochem Biophys Res Commun       Date:  2004-11-26       Impact factor: 3.575

Review 2.  Anti-TGF-beta strategies for the treatment of chronic liver disease.

Authors:  Katja Breitkopf; Stephan Haas; Eliza Wiercinska; Manfred V Singer; Steven Dooley
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

Review 3.  IL-6 signal transduction and its physiological roles: the signal orchestration model.

Authors:  D Kamimura; K Ishihara; T Hirano
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-05       Impact factor: 5.545

4.  Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis.

Authors:  K Toda; N Kumagai; K Tsuchimoto; H Inagaki; T Suzuki; T Oishi; K Atsukawa; H Saito; T Morizane; T Hibi; H Ishii
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

5.  Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

Authors:  Samuele De Minicis; Ekihiro Seki; Hiroshi Uchinami; Johannes Kluwe; Yonghui Zhang; David A Brenner; Robert F Schwabe
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

6.  Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients.

Authors:  Annunziata Lapolla; Eugenio Ragazzi; Barbara Andretta; Domenico Fedele; Michela Tubaro; Roberta Seraglia; Laura Molin; Pietro Traldi
Journal:  J Am Soc Mass Spectrom       Date:  2007-02-22       Impact factor: 3.109

7.  Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.

Authors:  A M Tiggelman; W Boers; C Linthorst; H S Brand; M Sala; R A Chamuleau
Journal:  J Hepatol       Date:  1995-09       Impact factor: 25.083

8.  Colocalization of three types of intermediate filament proteins in perisinusoidal stellate cells: glial fibrillary acidic protein as a new cellular marker.

Authors:  G Buniatian; R Gebhardt; D Schrenk; B Hamprecht
Journal:  Eur J Cell Biol       Date:  1996-05       Impact factor: 4.492

9.  Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA microarray.

Authors:  Xiao-Jing Liu; Li Yang; Feng-Ming Luo; Hong-Bin Wu; Qu Qiang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

10.  PPAR Gamma and Hepatic Stellate Cells.

Authors:  Saswati Hazra; Takeo Miyahara; Richard A Rippe; Hidekazu Tsukamoto
Journal:  Comp Hepatol       Date:  2004-01-14
View more
  19 in total

1.  Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.

Authors:  Ashley M Lakner; Nury M Steuerwald; Tracy L Walling; Sriparna Ghosh; Ting Li; Iain H McKillop; Mark W Russo; Herbert L Bonkovsky; Laura W Schrum
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

2.  Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition.

Authors:  Tung-Hung Su; Chung-Wai Shiau; Ping Jao; Chen-Hua Liu; Chun-Jen Liu; Wei-Tien Tai; Yung-Ming Jeng; Hung-Chih Yang; Tai-Chung Tseng; Hsiang-Po Huang; Huei-Ru Cheng; Pei-Jer Chen; Kuen-Feng Chen; Jia-Horng Kao; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

3.  IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.

Authors:  Jue Wei; Min Shi; Wei-Qi Wu; Hui Xu; Ting Wang; Na Wang; Jia-Li Ma; Yu-Gang Wang
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

4.  Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

Authors:  Michaela Granzow; Robert Schierwagen; Sabine Klein; Benita Kowallick; Sebastian Huss; Markus Linhart; Irela G Reza Mazar; Jan Görtzen; Annabelle Vogt; Frank A Schildberg; Maria A Gonzalez-Carmona; Alexandra Wojtalla; Benjamin Krämer; Jacob Nattermann; Sören V Siegmund; Nikos Werner; Dieter O Fürst; Wim Laleman; Percy Knolle; Vijay H Shah; Tilman Sauerbruch; Jonel Trebicka
Journal:  Hepatology       Date:  2014-05-06       Impact factor: 17.425

5.  Nonmuscle myosin II regulates migration but not contraction in rat hepatic stellate cells.

Authors:  Cathy C Moore; Ashley M Lakner; Christopher M Yengo; Laura W Schrum
Journal:  World J Hepatol       Date:  2011-07-27

6.  Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.

Authors:  Yan Liu; Heng Liu; Christoph Meyer; Jun Li; Silvio Nadalin; Alfred Königsrainer; Honglei Weng; Steven Dooley; Peter ten Dijke
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

7.  The regulatory roles of microRNA-146b-5p and its target platelet-derived growth factor receptor α (PDGFRA) in erythropoiesis and megakaryocytopoiesis.

Authors:  Peng-Fei Zhai; Fang Wang; Rui Su; Hai-Shuang Lin; Chong-Liang Jiang; Gui-Hua Yang; Jia Yu; Jun-Wu Zhang
Journal:  J Biol Chem       Date:  2014-06-30       Impact factor: 5.157

8.  Overexpression of pim-3 and protective role in lipopolysaccharide-stimulated hepatic stellate cells.

Authors:  Lin-Hua Liu; Qi-Nan Lai; Jian-Yong Chen; Ji-Xiang Zhang; Bin Cheng
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

9.  The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells.

Authors:  Saeideh Nakhaei-Rad; Hossein Nakhaeizadeh; Silke Götze; Claus Kordes; Iris Sawitza; Michèle J Hoffmann; Manuel Franke; Wolfgang A Schulz; Jürgen Scheller; Roland P Piekorz; Dieter Häussinger; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2016-02-16       Impact factor: 5.157

10.  Kinin-B2 receptor activity determines the differentiation fate of neural stem cells.

Authors:  Cleber A Trujillo; Priscilla D Negraes; Telma T Schwindt; Claudiana Lameu; Cassiano Carromeu; Alysson R Muotri; João B Pesquero; Débora M Cerqueira; Micheli M Pillat; Héllio D N de Souza; Lauro T Turaça; José G Abreu; Henning Ulrich
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.